what do i need to know about using nivolumab and ipilimumab together to treat kidney cancer?
Published 3 years ago • 231 plays • Length 2:54Download video MP4
Download video MP3
Similar videos
-
4:39
nivolumab and ipilimumab for metastatic kidney cancer
-
3:23
nivolumab improves overall survival for advanced kidney cancer
-
6:51
success for ipilimumab and nivolumab combo in advanced melanoma
-
1:55
investigating responses to nivolumab and ipilimumab in advanced rcc
-
3:19
radvax: nivolumab / ipilimumab with sbrt for metastatic renal cell carcinoma
-
9:09
nivolumab with alternatively scheduled ipilimumab in first-line treatment of advanced rcc
-
8:26
front-line therapy with nivolumab and salvage nivolumab ipilimumab in patients with advanced rcc
-
4:43
nivolumab in renal cell carcinoma
-
6:52
nivolumab in renal cell carcinoma
-
4:46
sbrt in combination with ipilimumab/nivolumab in mrcc
-
45:36
patient to patient: what you need to know about cancer immunotherapy
-
2:10
dr. weber on the toxicity profile of nivolumab versus ipilimumab for melanoma
-
1:30
targeted therapies for the treatment of mrcc after nivolumab-ipilimumab failure
-
2:37
key unmet needs in kidney cancer
-
1:39
advancements in use of combination drugs in clinical trials: nivolumab, pembrolizumab, and more
-
1:39
dr. elizabeth plimack on nivolumab in kidney cancer
-
6:28
risk stratification in metastatic renal cell carcinoma
-
0:49
immune checkpoint inhibition could be the future of renal cell carcinoma treatment
-
1:34
dr. sharpless on managing toxicities with nivolumab/ipilimumab in melanoma